Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy
出版年份 2023 全文链接
标题
Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy
作者
关键词
-
出版物
Science Translational Medicine
Volume 15, Issue 714, Pages -
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2023-09-01
DOI
10.1126/scitranslmed.adi1145
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and safety of cilta-cel in patients with progressive MM after exposure to other BCMA-targeting agents
- (2022) Adam D. Cohen et al. BLOOD
- Bispecific antibodies for the treatment of B-cell lymphoma: Promises, unknowns and opportunities
- (2022) Lorenzo Falchi et al. BLOOD
- A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma
- (2022) Emmanuel Bachy et al. NATURE MEDICINE
- Clonal Dynamics of HDR-Edited HSPCs Targeting the CD33 Locus in Rhesus Macaques
- (2022) Byung-Chul Lee et al. BLOOD
- Global detection of DNA repair outcomes induced by CRISPR–Cas9
- (2021) Mengzhu Liu et al. NUCLEIC ACIDS RESEARCH
- CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy
- (2021) Miriam Y. Kim et al. JCI Insight
- Clinical Experience in the Randomized Phase 3 Sierra Trial: Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Conditioning Enables Hematopoietic Cell Transplantation with Successful Engraftment and Acceptable Safety in Patients with Active, Relapsed/Refractory AML Not Responding to Targeted Therapies
- (2021) Boglarka Gyurkocza et al. BLOOD
- Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity
- (2020) Michelle F. Richter et al. NATURE BIOTECHNOLOGY
- Tuning the Antigen Density Requirement for CAR T-cell Activity
- (2020) Robbie G. Majzner et al. Cancer Discovery
- CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions
- (2020) Sherly Mardiana et al. Frontiers in Oncology
- Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
- (2020) Andrew V. Anzalone et al. NATURE BIOTECHNOLOGY
- Gene-edited stem cells enable CD33-directed immune therapy for myeloid malignancies
- (2019) Florence Borot et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ADCT-402, a PBD dimer–containing antibody drug conjugate targeting CD19-expressing malignancies
- (2018) Francesca Zammarchi et al. BLOOD
- Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia
- (2018) Miriam Y. Kim et al. CELL
- p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
- (2018) Robert J. Ihry et al. NATURE MEDICINE
- Engineering resistance to CD33-targeted immunotherapy in normal hematopoiesis by CRISPR/Cas9-deletion of CD33 exon 2
- (2018) Olivier Humbert et al. LEUKEMIA
- Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase
- (2017) Alec J. Walker et al. MOLECULAR THERAPY
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
- (2017) Nicole M. Gaudelli et al. NATURE
- Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
- (2017) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- Initiation of T cell signaling by CD45 segregation at 'close contacts'
- (2016) Veronica T Chang et al. NATURE IMMUNOLOGY
- Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
- (2016) Hagop M. Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lineage Switch in MLL-Rearranged Infant Leukemia Following CD19-Directed Therapy
- (2016) Ahmad Rayes et al. PEDIATRIC BLOOD & CANCER
- CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity
- (2016) Elad Jacoby et al. Nature Communications
- CD45 phosphatase is crucial for human and murine acute myeloid leukemia maintenance through its localization in lipid rafts
- (2016) Laetitia Saint-Paul et al. Oncotarget
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Easy quantitative assessment of genome editing by sequence trace decomposition
- (2014) Eva K. Brinkman et al. NUCLEIC ACIDS RESEARCH
- The large ectodomains of CD45 and CD148 regulate their segregation from and inhibition of ligated T-cell receptor
- (2013) S.-P. Cordoba et al. BLOOD
- Regulation of Src Family Kinases Involved in T Cell Receptor Signaling by Protein-tyrosine Phosphatase CD148
- (2011) Ondrej Stepanek et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3
- (2010) M Wunderlich et al. LEUKEMIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search